The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Notice of Interim Results

8 Sep 2023 07:00

RNS Number : 7749L
Directa Plus PLC
08 September 2023
 

 

8 September 2023

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Notice of Interim Results and Investor Presentations

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, confirms it expects to announce its results for the six months ended 30 June 2023 on Wednesday, 27 September 2023. In addition, management will host a live virtual presentation and Q&A for analysts at 10a.m. on the morning of publication of the results and a live virtual presentation and Q&A for retail investors on Friday, 29 September 2023 at 11a.m. on the Investor Meet Company platform.

 

Both presentations will be given by Giulio Cesareo, Chief Executive Officer, and Giorgio Bonfanti, Chief Financial Officer.

 

Questions can be submitted at any time during the live presentations.

 

A recording of the presentation will be made available on the Company's website following the conclusion of the investor presentation.

 

Analyst Presentation

 

To register to attend, please email directaplus@almapr.co.uk

 

Retail Investor Presentation

 

To register to attend, please do so here

 

Directa Plus plc

Giulio Cesareo, CEO

Giorgio Bonfanti, CFO

 

+39 02 36714458

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Neil McDonald

Adam Rae

 

+44 131 220 6939

Singer Capital Markets Securities Limited (Joint Broker)

Rick Thompson

Phil Davies

 

+44 20 7496 3069

Alma PR (Financial PR Adviser)

Justine James

Hannah Campbell

Kinvara Verdon

+44 20 3405 0205

directaplus@almapr.co.uk

 

Notes to Editors

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.

 

Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORUBRNROKUKRAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.